Aptose Announces Updated Clinical Responses, Breadth of
Company Provides Comprehensive Clinical Update from Phase 1/2 TrialTuspetinib Continues to Deliver Single Agent Responses in r/r AML PatientsTuspetinib...
Source: globenewswire.com
Stay updated with breaking news from Continuous Dosing Ongoing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company Provides Comprehensive Clinical Update from Phase 1/2 TrialTuspetinib Continues to Deliver Single Agent Responses in r/r AML PatientsTuspetinib...